164 related articles for article (PubMed ID: 34697063)
21. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
You L; Guo X; Huang Y
Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3
Sun X; Xu Q; Zeng L; Xie L; Zhao Q; Xu H; Wang X; Jiang N; Fu P; Sang M
Cancer Med; 2020 Nov; 9(22):8685-8700. PubMed ID: 33040485
[TBL] [Abstract][Full Text] [Related]
23. TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells.
Ding Y; Yu AQ; Li CL; Fang J; Zeng Y; Li DS
Oncotarget; 2014 Sep; 5(18):8393-401. PubMed ID: 25245189
[TBL] [Abstract][Full Text] [Related]
24. Baicalin Inhibits Human Cervical Cancer Cells by Suppressing Protein Kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) Signaling Pathway.
Wang Q; Xu H; Zhao X
Med Sci Monit; 2018 Apr; 24():1955-1961. PubMed ID: 29610452
[TBL] [Abstract][Full Text] [Related]
25. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
26. Stabilization of HDAC1 via TCL1-pAKT-CHFR axis is a key element for NANOG-mediated multi-resistance and stem-like phenotype in immune-edited tumor cells.
Woo SR; Lee HJ; Oh SJ; Kim S; Park SH; Lee J; Song KH; Kim TW
Biochem Biophys Res Commun; 2018 Sep; 503(3):1812-1818. PubMed ID: 30060952
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling.
Wang DW; You D; Dong J; Liu TF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):496-506. PubMed ID: 30720156
[TBL] [Abstract][Full Text] [Related]
28. Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-κB.
Han SZ; Liu HX; Yang LQ; Cui LD; Xu Y
Biomed Pharmacother; 2017 Dec; 96():1403-1410. PubMed ID: 29169726
[TBL] [Abstract][Full Text] [Related]
29. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
[TBL] [Abstract][Full Text] [Related]
30. NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma.
Deng L; Zhang X; Xiang X; Xiong R; Xiao D; Chen Z; Liu K; Feng G
Technol Cancer Res Treat; 2021; 20():15330338211038492. PubMed ID: 34520294
[No Abstract] [Full Text] [Related]
31. Cytoplasmic NANOG-positive stromal cells promote human cervical cancer progression.
Gu TT; Liu SY; Zheng PS
Am J Pathol; 2012 Aug; 181(2):652-61. PubMed ID: 22683467
[TBL] [Abstract][Full Text] [Related]
32. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.
Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K
Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938
[TBL] [Abstract][Full Text] [Related]
33. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
[TBL] [Abstract][Full Text] [Related]
34. The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair.
Shafi AA; McNair CM; McCann JJ; Alshalalfa M; Shostak A; Severson TM; Zhu Y; Bergman A; Gordon N; Mandigo AC; Chand SN; Gallagher P; Dylgjeri E; Laufer TS; Vasilevskaya IA; Schiewer MJ; Brunner M; Feng FY; Zwart W; Knudsen KE
Nat Commun; 2021 Jan; 12(1):401. PubMed ID: 33452241
[TBL] [Abstract][Full Text] [Related]
35. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
36. SiRNA interfering STAT3 enhances DDP sensitivity in cervical cancer cells.
Huang LL; Rao W
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4098-4106. PubMed ID: 30024597
[TBL] [Abstract][Full Text] [Related]
37. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway.
Zhou JJ; Chen RF; Deng XG; Zhou Y; Ye X; Yu M; Tang J; He XY; Cheng D; Zeng B; Zhou QB; Li ZH
FEBS Lett; 2014 Feb; 588(4):566-73. PubMed ID: 24462277
[TBL] [Abstract][Full Text] [Related]
39. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
Qin S; Li Y; Cao X; Du J; Huang X
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin promotes expression of survivin via STAT3 activation and reduces sensitivity to cisplatin in cervical cancer cells.
Vázquez-Mellado MJ; Cortés-Ballinas LG; Blanco-Flores IC; Aguilar C; Vázquez-Gómez G; Rocha-Zavaleta L
Oncol Rep; 2019 Feb; 41(2):1333-1341. PubMed ID: 30483799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]